Pfizer Receivables 2010-2024 | PFE

Pfizer receivables for the quarter ending June 30, 2024 were $11.393B, a 11.36% increase year-over-year.

  • Pfizer receivables for 2023 were $11.177B, a 2.05% increase from 2022.
  • Pfizer receivables for 2022 were $10.952B, a 4.59% decline from 2021.
  • Pfizer receivables for 2021 were $11.479B, a 45.07% increase from 2020.

Pfizer Receivables 2010-2024 | PFE

  • Pfizer receivables for 2023 were $11.177B, a 2.05% increase from 2022.
  • Pfizer receivables for 2022 were $10.952B, a 4.59% decline from 2021.
  • Pfizer receivables for 2021 were $11.479B, a 45.07% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B